Literature DB >> 15596908

A study of complications arising from different methods of anesthesia used in high-dose-rate brachytherapy for cervical cancer.

Keith H C Lim1, Jiade J Lu, Christopher J Wynne, Michael F Back, Rahul Mukherjee, Khalil Razvi, Thomas P Shakespeare.   

Abstract

The purpose of this report is to review the complications related to different methods of anesthesia for high-dose-rate (HDR) brachytherapy for cervical carcinoma. All patients diagnosed with cervical cancer between 1999 and 2002 treated with 3-channel HDR brachytherapy were entered. Complications due to anesthesia for each fraction of brachytherapy were graded using the Common Toxicity Criteria. Eighty-four fractions of brachytherapy were delivered to 18 patients: 19 fractions with patients under general anesthesia (GA), 41 with patients under topical anesthesia and sedation, 5 with patients under paracervical nerve block, and 19 with patients under conscious sedation. Thirteen complications were reported: 12 related to GA and 1 due to paracervical nerve block. Of complications due to GA, 7 were grade 1 and 5 were grade 2. The complication due to paracervical nerve block (seizure) was grade 3. GA had significantly more complications than topical anesthesia or conscious sedation (both P < 0.001). HDR brachytherapy for cervical cancer under GA has significantly more complications than other methods. Given the increasing use of fractionated 3-channel brachytherapy, further investigation of risks and benefits of anesthetic techniques is required.

Entities:  

Mesh:

Year:  2004        PMID: 15596908     DOI: 10.1097/01.coc.0000128723.00352.ad

Source DB:  PubMed          Journal:  Am J Clin Oncol        ISSN: 0277-3732            Impact factor:   2.339


  10 in total

1.  Comparison of efficacy of meperidine and fentanyl in terms of pain management and quality of life in patients with cervical cancer receiving intracavitary brachytherapy: a double-blind, randomized controlled trial.

Authors:  Saengrawee Thanthong; Sirikorn Rojthamarat; Wipra Worasawate; Phongthara Vichitvejpaisal; Danupon Nantajit; Nantakarn Ieumwananontachai
Journal:  Support Care Cancer       Date:  2017-03-18       Impact factor: 3.603

2.  Does multimodal analgesia premedication improve the management of carcinoma cervix brachytherapy?

Authors:  Naveen Eipe; John Penning; Rya Boscariol; Rajiv Samant; Choan E
Journal:  Pain Res Manag       Date:  2012 Sep-Oct       Impact factor: 3.037

3.  Pain assessment during conscious sedation for cervical cancer high-dose-rate brachytherapy.

Authors:  H Bhanabhai; R Samant; C E; L Grenier; S Lowry
Journal:  Curr Oncol       Date:  2013-08       Impact factor: 3.677

4.  Combined general and regional anesthesia and effects on immune function in patients with benign ovarian tumors treated by laparoscopic therapy.

Authors:  Yong-Chong Cheng; Xiao-Bin Cheng; Xin-Jie Li; Feng-Zhao Wang; Zhi-Kui Li
Journal:  Int J Clin Exp Med       Date:  2013-09-01

5.  Brachytherapy implant insertion in head-and-neck cancer: Results of anaesthetic technique at a tertiary care hospital.

Authors:  Suruchi Ambasta; Satyen Parida; Priya Rudingwa; Sandeep Kumar Mishra
Journal:  Indian J Anaesth       Date:  2018-06

6.  Outpatient combined intracavitary and interstitial cervical brachytherapy: barriers and solutions to implementation of a successful programme - a single institutional experience.

Authors:  Poh Wee Tan; Vicky Y Koh; Johann I Tang
Journal:  J Contemp Brachytherapy       Date:  2015-06-29

7.  Brachytherapy boost and cancer-specific mortality in favorable high-risk versus other high-risk prostate cancer.

Authors:  Vinayak Muralidhar; Michael Xiang; Peter F Orio; Neil E Martin; Clair J Beard; Felix Y Feng; Karen E Hoffman; Paul L Nguyen
Journal:  J Contemp Brachytherapy       Date:  2016-02-29

Review 8.  Improving the efficiency of image guided brachytherapy in cervical cancer.

Authors:  Sophie Otter; Adrian Franklin; Mazhar Ajaz; Alexandra Stewart
Journal:  J Contemp Brachytherapy       Date:  2016-12-06

9.  Comparison of high-dose-rate intracavitary brachytherapy dosimetry with and without anesthesia in patients with cervical carcinoma.

Authors:  Daya N Sharma; Pritee Chaudhari; Seema Sharma; Leena Gupta; Pandjatcharam Jagadesan; Goura K Rath; Pramod K Julka
Journal:  J Appl Clin Med Phys       Date:  2014-03-06       Impact factor: 2.102

10.  Novel anesthetic technique for combined intracavitary and interstitial brachytherapy for cervix cancer in an outpatient setting.

Authors:  Yiat Horng Leong; Kenneth Hock Soon Tan; Bok Ai Choo; Vicky Yaling Koh; Johann I-Hsiung Tang
Journal:  J Contemp Brachytherapy       Date:  2017-06-23
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.